Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-20T17:28:30.134Z Has data issue: false hasContentIssue false
  • English
  • Français

Hospitalisation and costs for schizophrenia relapse treatment in Germany

Published online by Cambridge University Press:  16 April 2020

A. Spannheimer ,
U. Reitberger ,
J. Clouth  and
M. Lothgren
A. Spannheimer
Affiliation:
Kendle International Inc., USA
U. Reitberger
Affiliation:
Kendle International Inc., USA
J. Clouth
Affiliation:
Lilly Deutschland GmbH, Germany
M. Lothgren
Affiliation:
European Health Outcomes Research, Lilly Research Centre, UK

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Monday, 6 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 151s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.